An Open-label, Two-treatment, Two-period, Two-sequence, Crossover Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers.

Trial Profile

An Open-label, Two-treatment, Two-period, Two-sequence, Crossover Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Jul 2011

At a glance

  • Drugs Atorvastatin; Fimasartan
  • Indications Hypercholesterolaemia; Hyperlipoproteinaemia type II; Hyperlipoproteinaemia type III; Hypertension; Hypertriglyceridaemia; Low HDL cholesterol
  • Focus Pharmacokinetics
  • Most Recent Events

    • 14 Jul 2011 Results published in the Journal of Cardiovascular Pharmacology.
    • 14 Oct 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top